Literature DB >> 35538192

SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.

Yanina Ivashko-Pachima1,2, Maram Ganaiem1,2, Inbar Ben-Horin-Hazak1,2, Alexandra Lobyntseva1,2, Naomi Bellaiche1,2, Inbar Fischer2, Gilad Levy2, Shlomo Sragovich1,2, Gidon Karmon1,2, Eliezer Giladi1,2, Shula Shazman3, Boaz Barak2,4, Illana Gozes5,6.   

Abstract

De novo heterozygous mutations in activity-dependent neuroprotective protein (ADNP) cause autistic ADNP syndrome. ADNP mutations impair microtubule (MT) function, essential for synaptic activity. The ADNP MT-associating fragment NAPVSIPQ (called NAP) contains an MT end-binding protein interacting domain, SxIP (mimicking the active-peptide, SKIP). We hypothesized that not all ADNP mutations are similarly deleterious and that the NAPV portion of NAPVSIPQ is biologically active. Using the eukaryotic linear motif (ELM) resource, we identified a Src homology 3 (SH3) domain-ligand association site in NAP responsible for controlling signaling pathways regulating the cytoskeleton, namely NAPVSIP. Altogether, we mapped multiple SH3-binding sites in ADNP. Comparisons of the effects of ADNP mutations p.Glu830synfs*83, p.Lys408Valfs*31, p.Ser404* on MT dynamics and Tau interactions (live-cell fluorescence-microscopy) suggested spared toxic function in p.Lys408Valfs*31, with a regained SH3-binding motif due to the frameshift insertion. Site-directed-mutagenesis, abolishing the p.Lys408Valfs*31 SH3-binding motif, produced MT toxicity. NAP normalized MT activities in the face of all ADNP mutations, although, SKIP, missing the SH3-binding motif, showed reduced efficacy in terms of MT-Tau interactions, as compared with NAP. Lastly, SH3 and multiple ankyrin repeat domains protein 3 (SHANK3), a major autism gene product, interact with the cytoskeleton through an actin-binding motif to modify behavior. Similarly, ELM analysis identified an actin-binding site on ADNP, suggesting direct SH3 and indirect SHANK3/ADNP associations. Actin co-immunoprecipitations from mouse brain extracts showed NAP-mediated normalization of Shank3-Adnp-actin interactions. Furthermore, NAP treatment ameliorated aberrant behavior in mice homozygous for the Shank3 ASD-linked InsG3680 mutation, revealing a fundamental shared mechanism between ADNP and SHANK3.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35538192     DOI: 10.1038/s41380-022-01603-w

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  59 in total

1.  Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis.

Authors:  Shmuel Mandel; Gideon Rechavi; Illana Gozes
Journal:  Dev Biol       Date:  2006-12-01       Impact factor: 3.582

2.  Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes.

Authors:  Veronika Ostapcuk; Fabio Mohn; Sarah H Carl; Anja Basters; Daniel Hess; Vytautas Iesmantavicius; Lisa Lampersberger; Matyas Flemr; Aparna Pandey; Nicolas H Thomä; Joerg Betschinger; Marc Bühler
Journal:  Nature       Date:  2018-05-23       Impact factor: 49.962

3.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.

Authors:  F Kyle Satterstrom; Jack A Kosmicki; Jiebiao Wang; Michael S Breen; Silvia De Rubeis; Joon-Yong An; Minshi Peng; Ryan Collins; Jakob Grove; Lambertus Klei; Christine Stevens; Jennifer Reichert; Maureen S Mulhern; Mykyta Artomov; Sherif Gerges; Brooke Sheppard; Xinyi Xu; Aparna Bhaduri; Utku Norman; Harrison Brand; Grace Schwartz; Rachel Nguyen; Elizabeth E Guerrero; Caroline Dias; Catalina Betancur; Edwin H Cook; Louise Gallagher; Michael Gill; James S Sutcliffe; Audrey Thurm; Michael E Zwick; Anders D Børglum; Matthew W State; A Ercument Cicek; Michael E Talkowski; David J Cutler; Bernie Devlin; Stephan J Sanders; Kathryn Roeder; Mark J Daly; Joseph D Buxbaum
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

4.  Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex.

Authors:  Shmuel Mandel; Illana Gozes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

5.  Activity-dependent neuroprotective protein: a novel gene essential for brain formation.

Authors:  Albert Pinhasov; Shmuel Mandel; Arkady Torchinsky; Eliezer Giladi; Zipora Pittel; Andrew M Goldsweig; Stephen J Servoss; Douglas E Brenneman; Illana Gozes
Journal:  Brain Res Dev Brain Res       Date:  2003-08-12

6.  The contribution of de novo coding mutations to autism spectrum disorder.

Authors:  Ivan Iossifov; Brian J O'Roak; Stephan J Sanders; Michael Ronemus; Niklas Krumm; Dan Levy; Holly A Stessman; Kali T Witherspoon; Laura Vives; Karynne E Patterson; Joshua D Smith; Bryan Paeper; Deborah A Nickerson; Jeanselle Dea; Shan Dong; Luis E Gonzalez; Jeffrey D Mandell; Shrikant M Mane; Michael T Murtha; Catherine A Sullivan; Michael F Walker; Zainulabedin Waqar; Liping Wei; A Jeremy Willsey; Boris Yamrom; Yoon-ha Lee; Ewa Grabowska; Ertugrul Dalkic; Zihua Wang; Steven Marks; Peter Andrews; Anthony Leotta; Jude Kendall; Inessa Hakker; Julie Rosenbaum; Beicong Ma; Linda Rodgers; Jennifer Troge; Giuseppe Narzisi; Seungtai Yoon; Michael C Schatz; Kenny Ye; W Richard McCombie; Jay Shendure; Evan E Eichler; Matthew W State; Michael Wigler
Journal:  Nature       Date:  2014-10-29       Impact factor: 69.504

7.  Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.

Authors:  Anke Van Dijck; Anneke T Vulto-van Silfhout; Elisa Cappuyns; Ilse M van der Werf; Grazia M Mancini; Andreas Tzschach; Raphael Bernier; Illana Gozes; Evan E Eichler; Corrado Romano; Anna Lindstrand; Ann Nordgren; Malin Kvarnung; Tjitske Kleefstra; Bert B A de Vries; Sébastien Küry; Jill A Rosenfeld; Marije E Meuwissen; Geert Vandeweyer; R Frank Kooy
Journal:  Biol Psychiatry       Date:  2018-03-15       Impact factor: 13.382

8.  Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study.

Authors:  Yanina Ivashko-Pachima; Adva Hadar; Iris Grigg; Vlasta Korenková; Oxana Kapitansky; Gidon Karmon; Michael Gershovits; C Laura Sayas; R Frank Kooy; Johannes Attems; David Gurwitz; Illana Gozes
Journal:  Mol Psychiatry       Date:  2019-10-30       Impact factor: 15.992

9.  Autophagy has a key role in the pathophysiology of schizophrenia.

Authors:  A Merenlender-Wagner; A Malishkevich; Z Shemer; M Udawela; A Gibbons; E Scarr; B Dean; J Levine; G Agam; I Gozes
Journal:  Mol Psychiatry       Date:  2013-12-24       Impact factor: 15.992

10.  A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP.

Authors:  Céline Helsmoortel; Anneke T Vulto-van Silfhout; Bradley P Coe; Geert Vandeweyer; Liesbeth Rooms; Jenneke van den Ende; Janneke H M Schuurs-Hoeijmakers; Carlo L Marcelis; Marjolein H Willemsen; Lisenka E L M Vissers; Helger G Yntema; Madhura Bakshi; Meredith Wilson; Kali T Witherspoon; Helena Malmgren; Ann Nordgren; Göran Annerén; Marco Fichera; Paolo Bosco; Corrado Romano; Bert B A de Vries; Tjitske Kleefstra; R Frank Kooy; Evan E Eichler; Nathalie Van der Aa
Journal:  Nat Genet       Date:  2014-02-16       Impact factor: 38.330

View more
  3 in total

Review 1.  Neurotrophin Crosstalk in the Etiology and Treatment of Neuropsychiatric and Neurodegenerative Disease.

Authors:  Rajeev Joshi; Stephen R J Salton
Journal:  Front Mol Neurosci       Date:  2022-07-15       Impact factor: 6.261

2.  Hyperbaric Oxygen Therapy Alleviates Social Behavior Dysfunction and Neuroinflammation in a Mouse Model for Autism Spectrum Disorders.

Authors:  Inbar Fischer; Sophie Shohat; Gilad Levy; Ela Bar; Sari Schokoroy Trangle; Shai Efrati; Boaz Barak
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

3.  Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk.

Authors:  Maram Ganaiem; Gidon Karmon; Yanina Ivashko-Pachima; Illana Gozes
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.